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Abstract. Minimally invasive approaches have dramatically reduced mor-
bidity associated with adrenalectomy. There has been concern that an in-
creased frequency of adrenal imaging along with the advantages of less
morbidity could influence the indications for adrenalectomy. We tested the
hypothesis that adrenalectomy has become more common over time and
that benign diseases have been increasingly represented among procedural
indications. The Nationwide Inpatient Sample (NIS) database was utilized
to determine the incidence of adrenalectomy and the associated surgical
indications in the United States between 1988 and 2000. All discharged
patients were identified whose primary ICD-9-CM procedure code was for
adrenalectomy, regardless of the specific surgical approach (laparoscopic
adrenalectomy was not reliably coded). This subset was then queried for
associated ICD-9-CM diagnostic codes. Linear regression and t-tests were
utilized to determine the significance of trends. The total number of adre-
nalectomies increased significantly, from 12.9 per 100,000 discharges in
1988 to 18.5 per 100,000 discharges in 2000 (p = 0.000003). The total num-
ber of adrenalectomies with a primary ICD-9-CM code for malignant adre-
nal neoplasm did not increase significantly: from 1.2 per 100,000 dis-
charges in 1988 to 1.6 per 100,000 discharges in 2000 (p = 0.47). The total
number of adrenalectomies with a primary ICD-9-CM diagnostic code for
benign adrenal neoplasm increased significantly, from 2.8 per 100,000 dis-
charges in 1988 to 4.8 per 100,000 discharges in 2000 (p = 0.00002). The
average percentage of adrenalectomies performed for malignant neoplasm
was significantly higher during the period 1988–1993 when compared to
1994–2000 (11% vs. 9%; p = 0.002). The average percentage of adrenalec-
tomies performed for benign neoplasm was significantly lower during
1988–1993 when compared to 1994–2000 (25% vs. 28%; p = 0.015). Adre-
nalectomy is being performed with increasing frequency. This is associated
with an increase in the proportion of adrenalectomies performed for be-
nign neoplasms. Assuming no significant change in disease prevalence dur-
ing the study period, these data suggest that indications for adrenalectomy
may have changed somewhat over that period.
Operative intervention for diseases of the adrenal gland is rela-
tively young when considered against the background of the history
of surgery. However, perhaps more than any other field, we have
the seen the rapid advancement of the technologic capability in di-
agnosis and therapeutics played out in recent years in adrenal sur-
gery. Biochemical, molecular genetic, and imaging advances have
permitted earlier, more accurate diagnosis. The rapid development
and dissemination of new surgical instrumentation and techniques
have made possible operations with decreased morbidity and mor-
tality.
The endocrine surgical community witnessed a transformation in
1992 with the first report of a laparoscopic adrenalectomy [1]. This
ushered in the era of minimally invasive adrenal surgery. Since that
time there have been numerous modifications, specifically regard-
ing patient positioning and the anatomic approach [2–4]. Laparo-
scopic adrenalectomy has become the treatment of choice, and in
some cases even the gold standard, for some adrenal pathologies.
Many surgeons have reported series comparing traditional open
adrenalectomy to laparoscopic adrenalectomy [2, 3, 5–12], and
these reports have consistently demonstrated decreased length of
hospital stay, decreased use of postoperative analgesics, increased
rate of return to normal activities, and decreased late morbidity for
patients who have undergone the laparoscopic procedure.
Some controversy exists about the precise indications for opera-
tion across the spectrum of pathology that can affect the adrenal
glands. This is highlighted in the ongoing debate about the size at
which a nonfunctional, incidentally discovered adrenal mass should
be removed [13]. Moreover, as surgeons gain skill with laparoscopy,
adrenal lesions once thought safe to be removed only with an open
operation are being treated with a laparoscopic approach [14].
There have been few attempts to characterize practice patterns
for the utilization of adrenalectomy [15–17]. It has been a concern
that the increased occurrence of incidental adrenal imaging and the
availability of lower morbidity procedures may have lowered the
threshold or altered the indications for adrenalectomy [18, 19]. Pre-
vious reports have suggested too that the availability of minimally
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invasive procedures may lead to earlier surgical referral [20]. The
current study uses a database representative of surgical practice in
the Unites States to characterize trends in the use of adrenalecto-
my. Our aim was to evaluate the national experience with adrenal-
ectomy and determine if there has been a significant change in the
indications for adrenal surgery over time.
Methods
The Nationwide Inpatient Sample (NIS) is a stratified, cross-
sectional database that includes approximately 20% of all nonfed-
eral hospital discharges in the United States. It is stratified by geo-
graphic region, urban or rural location, teaching status, ownership,
and hospital size [21]. The NIS was born out of a federal, state, and
industrial partnership and is maintained under the Healthcare Cost
and Utilization Project of the Agency for Healthcare Research and
Quality. This study’s data were derived from the version of the NIS
database that encompasses the calendar years 1988 through 2000.
The number of states whose hospital discharges were represented
varied over the study period. There were 759 hospitals in eight
states in 1988 and 994 hospitals in 28 states in 2000 (Table 1). Par-
ticipating hospitals provide 100% of their discharge abstracts for a
particular calendar year. An average of 6.5 × 106 hospital dis-
charges per year are included in the NIS database. The database
was searched for the individual years 1988 through 2000, selecting
out all hospital discharges for which the primary International
Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) procedure code indicated adrenalectomy [22]. There
were a total of five distinct codes used in our algorithm to capture
all adrenal surgeries and to eliminate any bias of coding variation
(Table 2). During the study period, there was no unique ICD-9-CM
procedure code for laparoscopic adrenalectomy. An attempt was
made to identify from among our cohort those patients who under-
went laparoscopic adrenalectomy by searching for a modifier ICD-
9-CM procedural code that designated laparoscopy of the abdomi-
nal region (ICD-9-CM code 5421).
The set of hospital discharge abstracts identified from the NIS
were then further queried by primary ICD-9-CM diagnostic codes
in an attempt to quantify adrenalectomies performed for a variety
of common and uncommon adrenal disorders. The primary diag-
nostic codes identified were analyzed either individually or
grouped depending on the association with adrenal pathology.
Adrenal surgery performed for each diagnosis was expressed as the
number of surgeries for the diagnosis per 100,000 hospital dis-
charges per year. The number of procedures was normalized to ac-
count for variability in the total number of discharges per year in
the NIS. In addition, the percent of total adrenalectomies for each
year that was comprised by each diagnosis was determined. As an
indirect method of interrogating the impact of minimally invasive
adrenal surgery, the mean percentage of total adrenal surgeries
performed for each diagnosis was compared between years
grouped as 1988–1993 and 1994–2000, with the latter group repre-
senting a period during which laparoscopic adrenalectomy was well
accepted, widely practiced, and becoming a treatment of choice.
Simple linear regression analysis was used to determine the sig-
nificance of the trend in the number of adrenal surgeries per-
formed in total and for each diagnosis as a function of year. Two-
tailed student t-tests were used to compare mean percentages of
adrenal surgery by diagnosis between the grouping of years before
and after the introduction of laparoscopic adrenalectomy. A value
of p < 0.05 was considered statistically significant in all final analy-
ses. All statistical analyses were performed with SPSS version 11.5
(SPSS, Chicago, IL, USA).
Results
There were 677 patients identified in the NIS database who under-
went an adrenalectomy in 1988. There were a total of 5,242,904
hospital discharges encoded in the NIS database in 1988, yielding a
rate of 12.9 adrenal surgeries per 100,000 hospital discharges (Fig.
1). By 2000, there were 1378 patients whose hospital discharge in-
cluded one of the five primary ICD-9-CM procedure codes for
adrenal surgery. Given a total of 7,450,992 hospital discharges in-
cluded in the 2000 data, this yields a rate of 18.5 adrenal surgeries
per 100,000 hospital discharges. It shows a 43.4% increase in the
number of adrenalectomies performed in the United States be-
tween 1988 and 2000. This represents a statistically significant in-
crease in the frequency of adrenal operations performed per an-
num (p = 0.0000029).
We attempted to identify the patients whose adrenal surgery was
via a laparoscopic approach. There is no unique ICD-9-CM proce-
dure code for laparoscopic adrenalectomy, but there is a procedure
code (5421) for laparoscopy of the abdominal region. Querying the
cohort of adrenalectomy patients identified for each year of the
study period for this additional procedure code identified a range
from 1 patient (1990) to 107 patients (each 1999 and 2000) who
underwent both adrenalectomy and laparoscopy. When expressed
as a percent of total adrenalectomies per year, this ranged from
0.1% in 1990, 1991, and 1992 to 8.2% in 1999. There is clearly a
trend toward an increase in the proportion of adrenalectomies per-









1988 CA, CO, FL, IL, IA, MA, NJ, WA 759 5.2
1989 Added AZ, PA, WI 882 6.1
1993 Added CT, KS, MD, NY, OR, SC 913 6.5
1995 Added MO, TN 938 6.7
1997 Added GA, HI, UT 1012 7.1
1999 Added ME, VA 984 7.2
2000 AZ, CA, CO, CT, FL, GA, HI, IL,
IA, KS, KY, MA, MD, ME, MO,
NC, NJ, NY, OR, PA, SC, TN,
TX, UT, VA, WA, WI, WV (added
KY, NC, TX, WV)
994 7.5
Only those years with a change in the number of states participating are
shown. Data sources are denoted by two-letter state abbreviations.
Table 2. ICD-9-CM procedure codes used to query database.
072 Partial adrenalectomy
0721 Excision of lesion of adrenal gland
0722 Unilateral adrenalectomy
0729 Other partial adrenalectomy, NOS
073 Bilateral adrenalectomy, including excision of remaining
adrenal gland
5421 Laparoscopy of the abdominal region
NOS: not otherwise specified.
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formed via the laparoscopic approach. However, we thought that
this was not a reliable method of identifying laparoscopic adrenal-
ectomies as it still represented fewer than 10% of all adrenalecto-
mies. Other published series [17] and personal experience argue
that the percentage is significantly higher. Moreover, this method
identified a laparoscopic adrenalectomy in 1990, prior to the first
reported case [1].
The adrenalectomy patients identified were further classified ac-
cording to their primary ICD-9-CM diagnostic code. A total of 705
unique ICD-9-CM diagnostic codes were identified as primary di-
agnostic codes from the NIS entries for the adrenalectomy patients
identified. Many of these primary diagnostic codes were unrelated
to adrenal disorders and represent an artifact of hospital coding
and billing. Hospital discharge coding often reflects the overriding
medical concerns of an inpatient stay and is driven by reimburse-
ment issues rather than issues of diagnostic accuracy. The codes
were then held individually or grouped for further analysis. Tables
3 and 4 include a listing of the eight major diagnostic groups ana-
lyzed. Four of them (benign neoplasm of the adrenal, malignant
neoplasm of the adrenal, neoplasm of uncertain behavior of the
adrenal, and secondary malignant neoplasm of the adrenal) include
a single ICD-9-CM diagnostic code. The group labeled “disorders
of adrenal gland hormone secretion” includes several diagnostic
codes that were analyzed alone and in combination. The ICD-9-
CM code 2556, medulloadrenal hyperfunction, was not repre-
sented in the data set. Neoplasms of other abdominal and thoracic
organs, except urinary organs, includes multiple codes for tumors
of the esophagus, lung, breast, bowel, liver, pancreas, ovary, testis,
connective tissue, and retroperitoneum. Neoplasms of urinary or-
gans include tumors of the kidney, ureter, and bladder. The group
entitled “other” includes infectious etiologies, lymphomas, disease
of nonadrenal endocrine organs, psychiatric disorders, traumatic
injuries, complications in the puerperium, and disease of the circu-
latory, musculoskeletal, and cardiorespiratory systems.
The annual rate of adrenalectomies associated with a primary
ICD-9-CM diagnostic code for malignant neoplasm of the adrenal
gland did not significantly change: 1.2 per 100,000 hospital dis-
charges in 1988 and 1.6 per 100,000 discharges in 2000 (p = 0.47)
(Table 3). This is in contrast to the 71% increase in the annual rate
of adrenalectomies associated with a primary ICD-9-CM diagnos-
tic code for benign neoplasm of the adrenal gland. There was a
significant increase, from 2.8 per 100,000 discharges in 1988 to 4.8
per 100,000 discharges in 2000 (p = 0.000022) (Table 3). There was
also a significant increase in the annual rate of adrenalectomies
performed for an adrenal neoplasm of uncertain behavior (0.15 per
100,000 discharges in 1988 to 0.42 per 100,000 discharges in 2000, p
= 0.00357) (Table 3). There was a statistically significant increase
in the rate of adrenalectomies with a primary coded diagnosis of
hyperaldosteronism, adrenal gland disorder not otherwise speci-
fied, and secondary malignant neoplasm of the adrenal gland
(Table 3). It is also interesting to note that there has been a signifi-
cant increase in the rate of adrenal surgeries associated with a pri-
mary diagnostic code in the group of other abdominal and thoracic
organ neoplasms. The rate of adrenalectomies performed for each
of the remaining adrenal-specific diagnostic codes (Cushing syn-
drome, adrenogenital disorder, other corticoadrenal hyperactivity,
and corticoadrenal insufficiency) did not evidence any significant
trend over the course of the study period (Table 3), but many of
these cases are likely coded as benign neoplasms of the adrenal
gland.
Laparoscopic adrenalectomy was first reported in 1992 [1]. The
technique became relatively widely disseminated by 1993. We
therefore divided our study period into two groups, 1988–1993 and
1994–2000, to assess indirectly the impact of laparoscopic surgery
on the use of adrenalectomy. The average annual percent of adre-
nalectomies performed for primary malignant neoplasms of the
adrenal gland significantly decreased from 11% in 1988–1993 to
9% in 1994–2000 (p = 0.002) (Table 4). The average annual per-
cent of adrenalectomies performed for benign neoplasm of the
adrenal gland significantly increased: from 25% in 1988–1993 to
28% in 1994–2000 (p = 0.015) (Table 4). The average annual per-
cent of adrenalectomies performed for adrenal neoplasms of un-
certain behavior significantly increased as well: from 1.4% in 1988–
1993 to 1.9% in 1994–2000 (p = 0.034) (Table 4). The remaining
adrenal-specific diagnoses, as well as those procedures with a pri-
mary diagnostic code unrelated to primary adrenal pathology, did
not evidence any difference in the proportion of adrenal surgeries
they comprise when compared between the earlier and later years
of the study period. Figure 2 shows the overall composition of ad-
renalectomies performed in the United States from 1988 through
2000. Percentages associated with each section of the graph repre-
sent the mean percentage for the year grouping as shown in Table
4. Figure 2a includes 6 years and 5096 total adrenalectomies. Fig-
ure 2b includes 7 years and 8133 total adrenalectomies.
Discussion
Adrenal disorders often result in the need for surgical therapy as a
primary therapeutic intervention (e.g., for adrenal carcinoma and
pheochromocytoma), a diagnostic maneuver (e.g., for an inciden-
tally discovered adrenal neoplasm), or an end-stage intervention
when medical therapy risks toxicity or ceases to be effective (e.g.,
for some cases of Cushing syndrome). The approach to adrenal
surgery was revolutionized in 1992 with the introduction of the lap-
aroscopic adrenalectomy [1]. This procedure has allowed surgeons
to perform this still relatively uncommon procedure with lower
morbidity and mortality. However, as is often a concern with new,
successful technology, we must determine if the technology itself
influences its use.
Fig. 1. Annual rate of adrenalectomies from 1988 through 2000 in the
United States. Data points are the annual number of adrenalectomies per
100,000 hospital discharges.
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This study demonstrates that the annual rate of adrenal surgery
has significantly increased in the United States between 1988 and
2000. This trend has also been found in several smaller series ex-
amining a variety of aspects of adrenal surgery [17, 23, 24]. What
may account for this increase in the use of adrenal surgery? Others
have postulated that it may reflect an increase in the incidence of
adrenal imaging [18, 19]. Much of this imaging is done incidentally
during examinations for other abdominal or retroperitoneal pa-
thology. Furthermore, the quality of imaging technology has im-
proved such that subtle adrenal cortical irregularities are being de-
tected at a higher rate [18].
The increased total annual number of adrenal surgeries may also
represent a trend toward surgical referral earlier in the course of
the disease. One study looking at adrenalectomy for aldosterone-
secreting adrenocortical tumors demonstrated that both the level
of diastolic blood pressure elevation and the extent of hyperkale-
mia were less severe in a group of patients treated between 1993
and 1998 when compared to a comparable group of patients treated
from 1975 to 1986 [20]. Such earlier referral for surgery was
thought to be secondary to the actual and perceived decreased
morbidity from minimally invasive surgical intervention. Although
no studies have addressed this possibility to date, it may be that the
morbidity due to minimally invasive adrenal surgery for primary
hyperaldosteronism has decreased enough such that there is now a
threshold at which the risk of morbidity from sustained exposure to
antihypertensive medications may exceed the risk from surgery.
The composition of the disease-specific indications for adrenal-
ectomy has changed too between 1988 and 2000. The total annual
rate of adrenalectomies for benign neoplasms of the adrenal gland
and for neoplasms of uncertain behavior has increased signifi-
cantly, whereas the rate of adrenalectomies for primary malignant
neoplasms of the adrenal gland has not. Furthermore, adrenalec-
tomy for malignancies metastatic to the adrenal gland is being per-
formed at a significantly higher rate relative to that in 1988. In
agreement with previous studies [20], the rate of adrenal surgery
for hyperaldosteronism increased from 1988 to 2000. The other
specific disorders of adrenal hormone secretion did not demon-
strate a significant change over the time period reviewed. However,
it must be noted that the absolute numbers of procedures for these
other diagnoses are small and that many of the diagnoses were
likely coded as benign, irrespective of hormonal function.
The NIS is a well validated database used to perform research on
health care delivery and resource utilization [25–31]. It provides a
cross-sectional survey across all payers. However, the database is
not inclusive of all surgical practice in the United States. Its 20%
sample does not include procedures performed at Veterans Ad-
Table 3. Annual rate of adrenalectomy for selected ICD-9-CM diagnostic codes.
Diagnosis ICD-9-CM code 1988a 2000a p*
Malignant neoplasm of the adrenal gland 1940 1.24 1.56 0.47
Benign neoplasm of the adrenal gland 2270 2.82 4.83 0.000022
Neoplasm of uncertain behavior of the adrenal gland 2372 0.15 0.42 0.00357
Disorders of adrenal gland hormone secretion
Cushing syndrome 2550 0.19 0.32 0.832
Hyperaldosteronism 2551 0.15 0.28 0.015
Adrenogenital disorder 2552 0.02 0.04 0.121
Other corticoadrenal overactivity 2553 0 0.03 0.43
Corticoadrenal insufficiency 2554 0.06 0.04 0.611
Adrenal gland disorder NOS 2558, 2559 0.57 0.74 0.004
Secondary malignant neoplasm of the adrenal gland 1987 0.59 0.66 0.037
Neoplasmb of other abdominal and thoracic organs (except urinary organs) — 0.92 1.77 0.000021
Neoplasmb of urinary organs — 3.61 4.19 0.096
Other — 2.59 3.53 0.595
aNumber of adrenalectomies per 100,000 hospital discharges.
bIncludes benign, malignant, uncertain behavior, and secondary neoplasms.
*Simple linear regression.
Table 4. Average annual percentage of adrenalectomies for selected ICD-9-CM diagnostic codes.
Diagnosis ICD-9-CM code 1988–1993a (%) 1994–2000a (%) p*
Malignant neoplasm of the adrenal gland 1940 10.89 ± 1.07 8.96 ± 0.68 0.002
Benign neoplasm of the adrenal gland 2270 24.88 ± 2.03 28.01 ± 1.88 0.015
Neoplasm of uncertain behavior of the adrenal gland 2372 1.38 ± 0.31 1.91 ± 0.46 0.034
Disorders of adrenal gland hormone secretion
Cushing syndrome 2550 1.76 ± 0.55 1.31 ± 0.31 0.101
Hyperaldosteronism 2551 1.04 ± 0.16 1.17 ± 0.48 0.515
Adrenogenital disorder 2552 0.14 ± 0.01 0.18 ± 0.07 0.502
Other corticoadrenal overactivity 2553 0.10 ± 0.00 0.11 ± 0.04 0.837
Corticoadrenal insufficiency 2554 0.60 ± 0.19 0.56 ± 0.29 0.763
Adrenal gland disorder NOS 2558, 2559 3.74 ± 0.68 4.14 ± 0.61 0.288
Secondary malignant neoplasm of the adrenal gland 1987 3.98 ± 0.83 4.04 ± 0.68 0.874
Neoplasmb of other abdominal and thoracic organs (except urinary organs) — 9.01 ± 1.27 9.58 ± 0.86 0.355
Neoplasmb of urinary organs — 30.15 ± 2.44 29.18 ± 3.75 0.60
Other — 12.20 ± 4.08 10.98 ± 3.96 0.593
aValues are ± standard deviation.
bIncludes benign, malignant, uncertain behavior, and secondary neoplasms.
*Two-tailed Student’s t-test.
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ministration hospitals, for example. Furthermore, some of the cen-
ters of excellence in endocrine surgery across the United States,
from which many of the large published series are generated, are
currently geographically excluded from the NIS. Therefore it is
necessary to extrapolate the significant patterns and trends that
have been detected in the NIS database.
The clinical detail of the NIS is somewhat limited by available
coding systems. This study identified 705 ICD-9-CM codes listed as
the primary diagnostic code of the adrenalectomy patients. The
breadth of these diagnostic codes suggests that they may be the
primary reason for the hospital stay rather than the indication for
the original procedure. This variability in hospital coding is inher-
ent in the use of administrative databases. However, the variability
in coding appears constant over the time period studied, with 50%
to 51% of the adrenalectomies during each period (1988–1993 and
1994–2000) being associated with a diagnostic code that grouped
them in “neoplasm of other abdominal and thoracic organs,” “neo-
plasm of urinary organs,” and “other.” Thus the relative rates and
percentages of adrenalectomies for specific diagnoses would not be
affected. The current iteration of the ICD codes does not include a
procedural code for laparoscopic adrenalectomy [22]. Attempts in
the current study to identify directly those patients who underwent
adrenalectomy via a laparoscopic approach were not successful,
likely due to variability in the use of modifier procedure codes (e.g.,
laparoscopy of the abdominal region). We identified as possible
laparoscopic adrenalectomies only a maximum of 8% of proce-
dures per year. Current estimates place the number at closer to
60% [17].
An alternative, indirect method to profile adrenal surgery is to
examine trends over time. As laparoscopic adrenalectomy became
the preferred approach during the latter half of the last decade, we
chose to look at the change in the percentage of adrenal surgery
being performed for a variety of indications before and after 1993.
The results demonstrate a significant change in the percentage of
adrenal surgery performed for benign versus malignant adrenal pa-
thology. There was a divergence in the relative percentages of these
two indications, as the percentage of adrenalectomy for primary
benign neoplasms significantly increased and that for adrenalecto-
my for primary malignant neoplasm significantly decreased. These
two specific diagnostic ICD-9-CM codes are the most informative
to examine, as the remainder of the diagnostic codes studied do not
specifically indicate the nature of the adrenal mass. Notably, how-
ever, the percentage of adrenalectomies performed for lesions
characterized as uncertain behavior also increased after 1993.
There was an increase in the proportion of adrenalectomies per-
formed in the United States for benign disease and disease of un-
certain behavior, a code that may be chosen by physicians before
the pathology is known. It is unlikely that the prevalence of these
pathologic entities changed appreciably during the 13-year time
span of this study. Therefore it appears that more adrenal surgery is
being performed for at least some lesions that have historically
been simply observed or perhaps never detected. The NIS database
does not include information about the size of the adrenal lesions
removed, but it is unlikely that all of the additional benign lesions
removed were > 6 cm in diameter. This increase correlates well
with the introduction of minimally invasive adrenal surgery. It is a
reasonable conclusion, then, that the low morbidity of laparoscopic
adrenalectomy has led many surgeons to remove adrenal lesions
that were previously only observed using serial imaging or bio-
chemical testing. This may be somewhat patient-driven. Minimally
invasive surgery is now often marketed directly to patients. More-
over, many patients prefer a definitive disposition to longitudinal
follow-up and the psychological stress of knowing that the lesion
might represent something other than a completely benign
adenoma.
Increased utilization of adrenal imaging is now detecting lesions
that are asymptomatic [18, 19]. However, it remains for the surgeon
to decide which lesions warrant operative intervention and which
ones can be simply observed. Without novel, long-term studies on
the natural history of adrenal lesions, we should not widen the in-
dications for surgery [4, 32, 33]. Some have argued to the contrary.
There have been proposals that any nonfunctioning tumor is an
indication for laparoscopic adrenalectomy [34]. Some have com-
promised and stated that any adrenal tumor > 2.5 cm in diameter
should be removed [35]. All of these arguments rely on the safety of
laparoscopic adrenalectomy. Although the laparoscopic approach
has been shown repeatedly to have a better morbidity profile than
the traditional open approach, it is not without risk [2, 3, 6, 10–12].
The traditional teaching of an acceptable negative appendectomy
rate [36] should not apply to adrenalectomy. There can be signifi-
cant deleterious consequences of an “exploratory” adrenalectomy.
Natural experimentation with new technologies allows the
spread of its use. It is in this context that some adrenal lesions ini-
tially not considered candidates for minimally invasive surgery
(e.g., pheochromocytoma) have been successfully removed via the
laparoscopic approach [14]. The appeal of laparoscopic adrenalec-
tomy is likely to encourage a continued trend toward increased use
of adrenalectomy. The currently demonstrated shift in indications
for adrenalectomy is statistically significant, though still relatively
small in magnitude. The clinical significance of this trend is not yet
fully known. Further prospective study, including the use of more
clinically oriented databases (e.g., the National Surgical Quality
Improvement Project) is needed to address these issues so we can
Fig. 2. Average annual percent of adrenalectomies by selected ICD-9-CM
diagnostic codes from 1988 through 1993 (A) and from 1994 through 2000
(B).
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prevent future overtreatment with a rational, evidence-based ap-
proach.
Conclusions
The total number and rate of operations for adrenal disease are
increasing in the United States, as is the percent of adrenalectomies
performed for benign or uncertain disease. The latter appears to
account for most of the rise in frequency of adrenal surgery. This
increase was most marked during the period after the introduction
of minimally invasive adrenal surgery. It is during this time period
as well that incidental adrenal imaging became more common-
place. Assuming that the prevalence of adrenal disease has not
changed over the last one-and-a-half decades, it appears that the
utilization of adrenalectomy has increased. We must be cautious
not to alter the indications for operation without pathophysiologic
evidence of need solely because our technical and surgical skill al-
low safer operations—or if we do, it should be with both good rea-
sons and strong evidence, and it should be prospectively monitored
and studied.
Résumé. La chirurgie mini-invasive (CMI) a radicalement réduit la
morbidité de la surrénalectomie. Un des soucis est que l’augmentation de la
fréquence de l’imagerie des surrénales combinée avec les avantages d’une
morbidité réduite par CMI pourraient influencer les indications de la
surrénalectomie. Nous avons testé l’hypothèse que la fréquence de la
surrénalectomie et que la prévalence de surrénalectomie pour maladie
bénigne ont augmenté avec le temps. On a utilisé la banque de données
« Nationwide Inpatient Sample (NIS) » pour déterminer l’incidence de la
surrénalectomie et les indications pour chirurgie aux Etats-Unis entre
1988 et 2000. Toute sortie de patient portant un code ICD-9-CM de procédé
primaire pour surrénalectomie, indépendamment de l’approche
chirurgicale (l’approche laparoscopique n’a pas été enregistrée avec
précision) a été ensuite comparée aux codes de diagnostic ICD-9-CM. On a
analysé la signification des tendances par régression linéaire et le test-t. Le
nombre total de surrénalectomies a augmenté de façon significative de 12.9
pour 100000 sorties en 1988 à 18.5 pour 100000 sorties en 2000 (p =
0.000003). Le nombre total de surrénalectomies avec un code ICD-9-CM
primaire pour néoplasme surrénalien malin n’a pas augmenté de façon
significative, passant de 1.2 pour 100000 sorties en 1988 à 1.6 pour 100000
sorties en 2000 (p = 0.47). Le nombre total de surrénalectomies avec le code
diagnostic primitif ICD-9-CM pour maladie bénigne de la surrénale a
augmenté de façon significative de 2.8 pour 100000 sorties en 1988 à 4.8
pour 100000 sorties en 2000 (p = 0.00002). Le pourcentage moyen de
surrénalectomies réalisées pour maladie maligne était significativement
plus élevé pendant la période 1988–1993 comparé à la période 1994–2000
(11% vs. 9%; p = 0.002). Le pourcentage moyen des surrénalectomies
réalisées pour maladie bénigne était significativement plus bas pendant la
période 1988-1993 comparé à la période 1994-2000 (25% vs. 28%; p =
0.015). La surrénalectomie se réalise avec une fréquence croissante, au
dépens d’une augmentation de la proportion de surénalectomies réalisées
pour maladie bénigne. En assumant qu’il n’y a eu aucune modification
significative dans la prévalence de la maladie pendant la période de l’étude,
ces données suggèrent que les indications de la surrénalectomie ont changé
pendant cette période de l’étude.
Resumen. Los abordajes mı́nimamente invasores han reducido la
morbilidad de la adrenalectomı́a en forma dramática. Ha habido
preocupación acerca de si la incrementada frecuencia de la imaginologı́a
suprarrenal junto con las ventajas de un procedimiento de menor
morbilidad podrı́an tener influencia sobre las indicaciones reales de la
adrenalectomı́a. Nos propusimos poner a prueba la hipótesis de que la
adrenalectomı́a se ha hecho más común con el transcurso del tiempo y que
las entidades benignas han venido a ser crecientemente frecuentes como
indicación para realizar el procedimiento. La base de datos de la
Nationwide Inpatient Sample (NIS) fue utilizada para determinar la
incidencia de la adrenalectomı́a y sus indicaciones en los Estados Unidos
en el periodo 1988 a 2000. Se identificaron todos los egresos cuyo código de
procedimento ICD-9-CM fuera para adrenalectomı́a, sin importar la vı́a de
abordaje (adrenalectomı́a laparoscópica no fue un código confiable), y el
subgrupo fue luego subdividido según los códigos diagnósticos ICD-9-CM
asociados. Se utilizaron pruebas de análisis de regresión y t-tests para
determinar la significancia de las tendencias. El número total de
adrenalectomı́as aumentó en forma significativa desde 12.9 por 100.000
egresos en 1988 a 18.5 por 100.000 egresos en 2000 (p = 0.000003). El
número total de adrenalectomı́as con el código diagnóstico ICD-9-CM
primario de neoplasma maligno no aumentó en forma significativa, de 1.2/
100.000 egresos en 1988 a 1.6/100.000 egresos en el 2000 (p = 0.47). El
número total de adrenalectomı́as con el código diagnóstico ICD-9-CM
primario de neoplasma suprarrenal benigno no aumentó
significativamente de 2.8/100.000 egresos en 1988 a 4.8/100.000 egresos en
el 2000 (p = 0.00002). El porcentaje promedio de adrenalectomı́as
practicadas por neoplasmas malignos fue significativamente más alto en el
periodo 1988-1993 que en 1994-2000 (11% vs. 9%, p = 0.002). El porcentaje
promedio de adrenalectomı́as por neoplasmas benignos fue
significativamente inferior en el periodo 1988-1993 que en el 1994–2000
(25% vs. 28%; p = 0.015). La adrenalectomı́a está siendo practicada con
creciente frecuencia, y esto se asocia con un incremento en la proporción de
adrenalectomı́as por neoplasmas benignos. Asumiendo que no ha habido
variación en la prevalencia durante el periodo del estudio, estos datos
sugieren que las indicaciones para la adrenalectomı́a puedan haber sufrido
algunos cambios en el curso de tal periodo.
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